495 related articles for article (PubMed ID: 8364280)
21. Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.
Barradell LB; Plosker GL; McTavish D
Drugs; 1993 Aug; 46(2):289-312. PubMed ID: 7691518
[TBL] [Abstract][Full Text] [Related]
22. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
[TBL] [Abstract][Full Text] [Related]
23. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.
Deshpande D; Gumbo T
Future Microbiol; 2011 Apr; 6(4):433-9. PubMed ID: 21526944
[TBL] [Abstract][Full Text] [Related]
25. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E
J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS.
Guthertz LS; Damsker B; Bottone EJ; Ford EG; Midura TF; Janda JM
J Infect Dis; 1989 Dec; 160(6):1037-41. PubMed ID: 2584751
[TBL] [Abstract][Full Text] [Related]
27. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
[TBL] [Abstract][Full Text] [Related]
28. Activity of antimicrobial agents against Mycobacterium avium-intracellulare complex (MAC) strains isolated in Italy from AIDS-patients.
Fattorini L; Hu CQ; Jin SH; Santoro C; Tsang AY; Mascellino MT; Mandler F; Orefici G
Zentralbl Bakteriol; 1992 Apr; 276(4):512-20. PubMed ID: 1611208
[TBL] [Abstract][Full Text] [Related]
29. [Azithromycin and Mycobacterium avium infection].
Perronne C
Pathol Biol (Paris); 1995 Jun; 43(6):565-7. PubMed ID: 8539084
[TBL] [Abstract][Full Text] [Related]
30. Minimum inhibitory concentrations of azithromycin in clinical isolates of
Uwamino Y; Aoki W; Inose R; Kamoshita Y; Mikita K; Namkoong H; Nishimura T; Matsushita H; Hasegawa N
Microbiol Spectr; 2024 Jun; 12(6):e0021824. PubMed ID: 38687080
[TBL] [Abstract][Full Text] [Related]
31. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
33. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774.
Yajko DM; Nassos PS; Sanders CA; Hadley WK
Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581
[TBL] [Abstract][Full Text] [Related]
34. Disseminated Mycobacterium avium complex infection.
Inderlied CB; Kemper CA
AIDS Clin Rev; 1992; ():131-72. PubMed ID: 1606056
[No Abstract] [Full Text] [Related]
35. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
van Ingen J; Egelund EF; Levin A; Totten SE; Boeree MJ; Mouton JW; Aarnoutse RE; Heifets LB; Peloquin CA; Daley CL
Am J Respir Crit Care Med; 2012 Sep; 186(6):559-65. PubMed ID: 22744719
[TBL] [Abstract][Full Text] [Related]
36. Mycobacterium avium complex in HIV-infected Thai children.
Phongsamart W; Chokephaibulkit K; Chaiprasert A; Vanprapa N; Chearskul S; Lolekha R
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S682-9. PubMed ID: 12403247
[TBL] [Abstract][Full Text] [Related]
37. Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.
Grosset J; Ji B
Drugs; 1997; 54 Suppl 2():23-7; discussion 28-9. PubMed ID: 9358197
[TBL] [Abstract][Full Text] [Related]
38. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
Dautzenberg B
Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
[TBL] [Abstract][Full Text] [Related]
40. New developments in the treatment of nontuberculous mycobacterial (NTM) disease.
Griffith DE; Wallace RJ
Semin Respir Infect; 1996 Dec; 11(4):301-10. PubMed ID: 8976583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
